Abstract
Analyzing the inflammatory microenvironment has become an important issue in the management of oral squamous cell carcinoma (OSCC). Pretreatment C-reactive protein (CRP) levels, leucocytes, monocytes, lymphocytes, neutrophils, basophils, eosinophils, platelets, neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) derived from the peripheral blood were analyzed. Receiver operating characteristic (ROC) curves determined a cut-off value for each parameter in 146 patients with OSCC compared with 93 controls and the results were associated with clinicopathological characteristics. CRP expression of tumors was measured by immunohistochemistry. ROC analysis determined cut-off values for CRP levels, leucocytes, monocytes, lymphocytes, neutrophils, NLR, dNLR, LMR, PLR and showed significant differences between the OSCC and control group. Compared with single laboratory tests calculated ratios were superior in measuring sensitivity and specificity of OSCC disease. NLR was significant directly associated and correlated with PLR. LMR was significant inversely associated and correlated with NLR and PLR. Immunohistochemical analysis did not show CRP expression of OSCCs. This study highlights the first analysis for cut-off values of pretreatment single laboratory tests and calculated ratios, which are strongly needed for a follow-up of cancer patients. Additionally, the calculated baselines can be used as a goal for successful immunotherapies in the future. The links between NLR, LMR, and PLR might be helpful for the clinical course (monitoring) of cancer patients and have been first described for OSCC in this study. Taken together, analyzing these data provides an additional practical guideline of further postoperative OSCC management.
Similar content being viewed by others
Abbreviations
- OSCC:
-
Oral squamous cell carcinoma
- CP:
-
Clinicopathological parameters
- CRP:
-
C-reactive protein
- WBCs:
-
White blood cells
- ROC:
-
Receiver operating characteristic
- NLR:
-
Neutrophil-to-lymphocyte ratio
- dNLR:
-
Derived NLR
- LMR:
-
Lymphocyte-to-monocyte ratio
- PLR:
-
Platelet-to-lymphocyte ratio
References
Grimm M (2012) Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC. Clin Transl Oncol 14(11):870–880. doi:10.1007/s12094-012-0867-2
Kreppel M, Eich HT, Kubler A, Zoller JE, Scheer M (2010) Prognostic value of the sixth edition of the UICC’s TNM classification and stage grouping for oral cancer. J Surg Oncol 102(5):443–449. doi:10.1002/jso.21547
Grandi C, Alloisio M, Moglia D, Podrecca S, Sala L, Salvatori P et al (1985) Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg 8(2):67–73
Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK et al (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97(6):1464–1470. doi:10.1002/cncr.11202
Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3–4):645–662. doi:10.1007/s10555-007-9082-y
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867. doi:10.1038/nature01322
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211–217. doi:10.1016/j.ccr.2005.02.013
Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431(7007):405–406
Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87(1):14–32 (87/1/14 [pii])
Grimm M, Lazariotou M (2012) Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma. Med Oncol 29(3):1435–1447. doi:10.1007/s12032-011-0045-3
Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L (2008) Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 68(11):4026–4030. doi:10.1158/0008-5472.CAN-08-0427
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118(3):285–296. doi:10.1016/j.cell.2004.07.013S0092867404006713
Fang HY, Huang XY, Chien HT, Chang JT, Liao CT, Huang JJ et al (2013) Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope 123(11):2690–2699. doi:10.1002/lary.24105
Chen YW, Chen IL, Lin IC, Kao SY (2014) Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma. Brit J Oral Maxillofac Surg 52(5):425–431. doi:10.1016/j.bjoms.2014.02.014
Tsai YD, Wang CP, Chen CY, Lin LW, Hwang TZ, Lu LF et al (2014) Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 36(7):947–953. doi:10.1002/hed.23400
Huang SH, Waldron JN, Milosevic M, Shen X, Ringash J, Su J et al (2015) Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer 121(4):545–555. doi:10.1002/cncr.29100
Grimm M, Feyen O, Hofmann H, Teriete P, Biegner T, Munz A et al (2015) Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue. Tumour Biol. doi:10.1007/s13277-015-4224-2
Lin GN, Peng JW, Liu DY, Xiao JJ, Chen YQ, Chen XQ (2014) Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy. Tumour Biol 35(11):10849–10854. doi:10.1007/s13277-014-2362-6
Glogauer JE, Sun CX, Bradley G, Magalhaes MA (2015) Neutrophils increase oral squamous cell carcinoma invasion through an invadopodia-dependent pathway. Cancer Immunol Res. doi:10.1158/2326-6066.CIR-15-0017
Magalhaes MA, Glogauer JE, Glogauer M (2014) Neutrophils and oral squamous cell carcinoma: lessons learned and future directions. J Leukoc Biol 96(5):695–702. doi:10.1189/jlb.4RU0614-294R
Wimazal F, Germing U, Kundi M, Noesslinger T, Blum S, Geissler P et al (2010) Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes. Cancer 116(10):2372–2381. doi:10.1002/cncr.25036
Jain M, Kasetty S, Khan S, Jain NK (2014) Tissue eosinophilia in head and neck squamous neoplasia: an update. Exp Oncol 36(3):157–161
Jain M, Kasetty S, Sudheendra US, Tijare M, Khan S, Desai A (2014) Assessment of tissue eosinophilia as a prognosticator in oral epithelial dysplasia and oral squamous cell carcinoma-an image analysis study. Pathol Res Int 2014:507512. doi:10.1155/2014/507512
Pereira MC, Oliveira DT, Kowalski LP (2011) The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol 56(4):353–358. doi:10.1016/j.archoralbio.2010.10.015
Buergy D, Wenz F, Groden C, Brockmann MA (2012) Tumor–platelet interaction in solid tumors. Int J Cancer 130(12):2747–2760. doi:10.1002/ijc.27441
Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ (2007) Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol 43(3):283–288. doi:10.1016/j.oraloncology.2006.03.010
Kargus S, Weber FE, Luebbers HT, Zemann W, Graetz KW, Kruse AL (2012) Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma? Oral Maxillofac Surg 16(2):197–200. doi:10.1007/s10006-011-0305-6
Perisanidis C, Kornek G, Poschl PW, Holzinger D, Pirklbauer K, Schopper C et al (2013) High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 30(1):334. doi:10.1007/s12032-012-0334-5
Sun W, Zhang L, Luo M, Hu G, Mei Q, Liu D et al (2015) Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: neutrophil-lymphocyte ratio and platelet–lymphocyte ratio. Head Neck. doi:10.1002/hed.24224
Rachidi S, Wallace K, Wrangle JM, Day TA, Alberg AJ, Li Z (2015) Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. doi:10.1002/hed.24159
Feng JF, Huang Y, Chen QX (2014) Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol 12:58. doi:10.1186/1477-7819-12-58
Feng JF, Huang Y, Zhao Q, Chen QX (2013) Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. Sci World J 2013:504365. doi:10.1155/2013/504365
Millrud CR, Mansson Kvarnhammar A, Uddman R, Bjornsson S, Riesbeck K, Cardell LO (2012) The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 7(12):e51120. doi:10.1371/journal.pone.0051120
Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG (2015) Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck 37(1):103–110. doi:10.1002/hed.23567
Deng Q, He B, Liu X, Yue J, Ying H, Pan Y et al (2015) Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med 13:66. doi:10.1186/s12967-015-0409-0
Tu XP, Qiu QH, Chen LS, Luo XN, Lu ZM, Zhang SY et al (2015) Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma. BMC Cancer 15:743. doi:10.1186/s12885-015-1727-6
Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):dju124. doi:10.1093/jnci/dju124
He JR, Shen GP, Ren ZF, Qin H, Cui C, Zhang Y et al (2012) Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 34(12):1769–1776. doi:10.1002/hed.22008
An X, Ding PR, Wang FH, Jiang WQ, Li YH (2011) Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 32(2):317–324. doi:10.1007/s13277-010-0124-7
Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS et al (2013) A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One 8(12):e83069. doi:10.1371/journal.pone.0083069
Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y (2015) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. doi:10.1016/j.ctrv.2015.10.003
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T et al (2014) Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-0146
Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J et al (2014) Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 9(6):e101119. doi:10.1371/journal.pone.0101119
Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH et al (2013) Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 13:350. doi:10.1186/1471-2407-13-350
Grimm M, Calgeer B, Teriete P, Biegner T, Munz A, Reinert S (2015) Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma? Clin Transl Oncol. doi:10.1007/s12094-015-1352-5
Driemel O, Hertel K, Reichert TE, Kosmehl H (2006) Current classification of precursor lesions of oral squamous cell carcinoma principles of the WHO classification 2005. Mund Kiefer Gesichtschir 10(2):89–93. doi:10.1007/s10006-006-0675-3
Sobin LH, Wittekind CH (2010) UICC. TNM classification of malignant tumors, 7th edn. Springer, Berlin
Hamilton SR, Aaltonen LA (2000) Pathology and genetics. Tumours of the digestive system, 3rd edn. IARC Press, Lyon
Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, Teriete P et al (2014) Association of cancer metabolism-related proteins with oral carcinogenesis-indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? J Transl Med 12:208. doi:10.1186/1479-5876-12-208
Walker RA (2006) Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 49(4):406–410. doi:10.1111/j.1365-2559.2006.02514.x
Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561–577
Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E et al (2015) Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol 33(9):388 e319–388-e325. doi:10.1016/j.urolonc.2014.06.004
Thomas JS, Kabbinavar F (2015) Metastatic clear cell renal cell carcinoma: a review of current therapies and novel immunotherapies. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2015.07.009
Hughes T, Klairmont M, Sharfman WH, Kaufman HL (2015) Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma. Cancer Biol Ther. doi:10.1080/15384047.2015.1095401
Cheriyan VT, Thomas C, Balaram P (2011) Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy. J Cancer Res Clin Oncol 137(10):1435–1444. doi:10.1007/s00432-011-1012-2
Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A (1987) Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 47(1):173–177
Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C et al (2006) Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 32(1):22–28 (00006676-200601000-00004 [pii])
Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137(2):425–428. doi:10.1016/j.jtcvs.2008.05.046
Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M et al (2001) Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 7(3 Suppl):947s–957s
Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI (2012) Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 91(1):167–181. doi:10.1189/jlb.0311177
Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U et al (2015) Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol 20(1):70–81. doi:10.1007/s10147-014-0672-8
Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H et al (2015) Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol 10(2):280–285. doi:10.1097/JTO.0000000000000399
Kim IY, You SH, Kim YW (2014) Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer. BMC Surg 14:94. doi:10.1186/1471-2482-14-94
Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C et al (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103(3):335–343. doi:10.1002/ijc.10775
Di Carlo E, Forni G, Musiani P (2003) Neutrophils in the antitumoral immune response. Chem Immunol Allergy 83:182–203
Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D et al (2002) Generation of biologically active angiostatin kringle 1–3 by activated human neutrophils. J Immunol 168(11):5798–5804
De Larco JE, Wuertz BR, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10(15):4895–4900. doi:10.1158/1078-0432.CCR-03-0760
Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134(1):230–234
Kay HD, Smith DL (1983) Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes. J Immunol 130(1):475–483
Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L et al (2004) Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Int J Biol Markers 19(2):135–140
Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM et al (1995) Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Am J Med 98(6):551–558
Naugler WE, Karin M (2008) The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14(3):109–119. doi:10.1016/j.molmed.2007.12.007
Fujita Y, Okamoto M, Goda H, Tano T, Nakashiro K, Sugita A et al (2014) Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. PLoS One 9(12):e110378. doi:10.1371/journal.pone.0110378
Anand M, Chodda SK, Parikh PM, Nadkarni JS (1998) Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis. Hematol Oncol 16(4):143–154
Torisu-Itakura H, Lee JH, Huynh Y, Ye X, Essner R, Morton DL (2007) Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients. J Immunother 30(8):831–838. doi:10.1097/CJI.0b013e318158795b
Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78. doi:10.1038/nrc1256
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899. doi:10.1016/j.cell.2010.01.025
Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N et al (2011) Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 3:2. doi:10.1186/1758-3284-3-2
Hasselbalch HC (2015) Smoking as a contributing factor for development of polycythemia vera and related neoplasms. Leuk Res. doi:10.1016/j.leukres.2015.09.002
Weir AB, Lewis JB Jr, Arteta-Bulos R (2011) Chronic idiopathic neutrophilia: experience and recommendations. South Med J 104(7):499–504. doi:10.1097/SMJ.0b013e31821ec7cc
Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B et al (2014) Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst. doi:10.1093/jnci/dju294
Jinno T, Kawano S, Maruse Y, Matsubara R, Goto Y, Sakamoto T et al (2015) Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep 33(5):2161–2168. doi:10.3892/or.2015.3838
Watanabe H, Iwase M, Ohashi M, Nagumo M (2002) Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol 38(7):670–679
O’Riordain MG, Falconer JS, Maingay J, Fearon KC, Ross JA (1999) Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism. Int J Oncol 15(4):823–827
Wigmore SJ, Fearon KC, Sangster K, Maingay JP, Garden OJ, Ross JA (2002) Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21(4):881–886
St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C et al (2004) Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(8):929–935. doi:10.1001/archotol.130.8.929
Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K (2003) Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus—significance as a tumor marker. Cancer Lett 192(1):89–95 (S0304383502006304 [pii])
Jabs WJ, Busse M, Kruger S, Jocham D, Steinhoff J, Doehn C (2005) Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 68(5):2103–2110. doi:10.1111/j.1523-1755.2005.00666.x
Acknowledgments
The authors thank the assistance of Dr. Julia Grimm for her technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent and research involving human participants
Written informed consent to participate was obtained from all patients (Ethics Committee Tuebingen, Germany, approval number: 562-2013BO2).
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Grimm, M., Rieth, J., Hoefert, S. et al. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma. Eur Arch Otorhinolaryngol 273, 3371–3384 (2016). https://doi.org/10.1007/s00405-016-3950-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-3950-4